SLC2A1 and diabetic kidney disease: Upon examining the association between SLC2A1 variants and type 2 diabetes leading to nephropathy, we selected as a control population the healthy subjects and not the patients with diabetes type 2 without nephropathy since every participant of the latter population is always a candidate to become a future case with diabetic nephropathy.